IP Library Granted Patent US 12,371,731
Granted Patent B2
US 12,371,731 · App. 18/322,200 · Granted Jul 29, 2025

Normalization of NGS library concentration

Inventors: Vladimir Makarov (Ann Arbor, MI); Sergey Chupreta (Gregory, MI)
Assignee: INTEGRATED DNA TECHNOLOGIES, INC.
C12Q1/6806C12N15/00C12Q1/686C12Q1/6876C40B40/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,371,731
App. No.
18/322,200
Granted
Jul 29, 2025
Kind
B2
Abstract

A bottleneck in the Next Generation Sequencing (NGS) workflow is the quantification of libraries for accurate pooling and loading of the sequencing instrument flow cell or chip. Disclosed herein are methods that improve performance and reduce time compared to existing methods.

Claims (25)

1. A kit comprising:

a first primer comprising a first portion, a second portion and a third portion, wherein the first portion is located at a 3′ end of the first primer, wherein the second portion comprises 3 or more consecutive ribonucleotide bases and is located 5′ to the first portion, and wherein the third portion is located 5′ adjacent to the second portion and comprises a low complexity sequence selected from the group consisting of poly(A), poly(T), poly(G), poly(C), poly(AG), poly(AC), poly(GT), poly(CT), poly(AT), poly(GC), a trinucleotide, a tetranucleotide, and a pentanucleotide;

a second primer, wherein the second primer comprises a second primer first portion, a second primer second portion comprising 3 or more consecutive ribonucleotide bases located 5′ adjacent to the second primer first portion and a second primer third portion located 5′ adjacent to the second primer second portion and comprising a low complexity sequence selected from the group consisting of poly(A), poly(T), poly(G), poly(C), poly(AG), poly(AC), poly(GT), poly(CT), poly(AT), poly(GC), a trinucleotide, a tetranucleotide, and a pentanucleotide;

a ligase selected from the group consisting of T4 DNA ligase, T3 DNA ligase, T7 DNA ligase, and E. coli DNA ligase;

an enzyme with 3′-5′ exonuclease activity; and

a probe, wherein the probe comprises a modification to provide resistance to digestion by the enzyme with 3′-5′ exonuclease activity, and wherein at least a portion of the probe is complementary to at least a portion of the second and third portion of the first primer including the three or more consecutive ribonucleotide bases and at least a portion of the low complexity sequence.

2. The kit of claim 1 , wherein the enzyme with 3′-5′ exonuclease activity is exonuclease III.

3. The kit of claim 1 , wherein the enzyme with 3′-5′ exonuclease activity is T4 DNA Polymerase.

4. The kit of claim 1 , wherein the ligase is T4 DNA ligase.

5. The kit of claim 1 , wherein the low complexity sequence of the first primer is poly(T).

6. The kit of claim 5 , wherein the low complexity sequence of the first primer is 10-20 bases.

7. The kit of claim 1 , wherein the low complexity sequence of the first primer is 10-20 bases.

8. The kit of claim 1 , wherein the enzyme with 3′-5′ exonuclease activity is exonuclease III, wherein the ligase is T4 DNA ligase, and wherein the low complexity sequence of the first primer is 10-20 bases.

9. The kit of claim 8 , wherein the low complexity sequence of the first primer is poly(T).

10. The kit of claim 8 , wherein the modification to provide resistance to digestion by the enzyme with 3′-5′ exonuclease activity comprises phosphorothioate linkages at the 5′ end of the probe.

11. The kit of claim 1 , wherein the low complexity sequence of the second primer is poly(T).

12. The kit of claim 11 , wherein the low complexity sequence of the second primer is 10-20 bases.

13. The kit of claim 1 , wherein the low complexity sequence of the second primer is 10-20 bases.

14. The kit of claim 1 , wherein the enzyme with 3′-5′ exonuclease activity is exonuclease III, wherein the ligase is T4 DNA ligase, and wherein the low complexity sequence of the second primer is 10-20 bases.

15. The kit of claim 14 , wherein the low complexity sequence of the second primer is poly(T).

16. The kit of claim 14 , wherein the modification to provide resistance to digestion by the enzyme with 3′-5′ exonuclease activity comprises at least four consecutive phosphorothioate linkages at the 5′ end of the probe.

17. The kit of claim 1 , wherein the enzyme with 3′-5′ exonuclease activity is exonuclease III, wherein the ligase is T4 DNA ligase, wherein the low complexity sequence of the first primer is 10-20 bases, wherein the low complexity sequence of the second primer is 10-20 bases, wherein the low complexity sequence of the first primer is poly(T), and wherein the low complexity sequence of the second primer is poly(T).

18. The kit of claim 17 , wherein the modification to provide resistance to digestion by the enzyme with 3′-5′ exonuclease activity comprises at least four consecutive phosphorothioate linkages at the 5′ end of the probe.

19. The kit of claim 18 , wherein the probe is single-stranded DNA.

20. The kit of claim 1 , wherein the probe is single-stranded DNA and wherein the modification to provide resistance to digestion by the enzyme with 3′-5′ exonuclease activity comprises phosphorothioate linkages at the 5′ end of the probe, and wherein the enzyme with 3′-5′ exonuclease activity is selected from the group consisting of T4 DNA Polymerase and exonuclease III.

Assignments (2)
MERGER Recorded Jan 6, 2025
From: SWIFT BIOSCIENCES, INC.
To: INTEGRATED DNA TECHNOLOGIES, INC.
Reel/Frame 069750/0323 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2025
From: MAKAROV, VLADIMIR; CHUPRETA, SERGEY
To: SWIFT BIOSCIENCES, INC.
Reel/Frame 069823/0480 →
Continuity (5)
Continuation 17214251 · Mar 26, 2021
Continuation 16294561 · Mar 6, 2019
Continuation PCTUS2017050354 · Sep 6, 2017
Provisional Application 62384118 · Sep 6, 2016
Related Publication 20240068011A1 · Feb 29, 2024
References Cited (33)
US 4988617A · Andegren et al. · 1991 [cited by applicant]
US 6297010B1 · Stefano · 2001 [cited by applicant]
US 7718403B2 · Kamberov et al. · 2010 [cited by applicant]
US 8455197B2 · Rand · 2013 [cited by applicant]
US 11697836B2 · Makarov · 2023 [cited by examiner]
US 20100129874A1 · Mitra et al. · 2010 [cited by applicant]
US 20120289414A1 · Mitra et al. · 2012 [cited by applicant]
US 20140378317A1 · Fu et al. · 2014 [cited by applicant]
US 20160046987A1 · Kim et al. · 2016 [cited by applicant]
CN 104619894A · 2015 [cited by applicant]
CN 104830961A · 2015 [cited by applicant]
JP 2006519621A5 · 2007 [cited by applicant]
JP 2010539956A5 · 2011 [cited by applicant]
JP 2014057565A · 2014 [cited by applicant]
JP 2015510766A5 · 2016 [cited by applicant]
WO 2001061036A2 · 2001 [cited by applicant]
WO 2012044847A1 · 2012 [cited by applicant]
WO 2013138536A1 · 2013 [cited by applicant]
WO 2014047678A1 · 2014 [cited by applicant]
WO 2018048957A3 · 2015 [cited by applicant]
WO 2015134552A1 · 2015 [cited by applicant]
Lin et al., “Isolation, Characterization, and Kinetic Properties of Truncated Forms of T4 DNA Polymerase That Exhibit 3′-5′ Exonuclease Activity,” The Journal of Biological Chemistry, July, vol. 269, No. 30, pp. 19286-1… [cited by examiner]
Gilar et al., “Study of phosphorothioate-modified oligonucleotide resistance to 3′-exonuclease using capillary electrophoresis,” Journal of Chromatography B, vol. 714, pp. 13-20. (Year: 1998). [cited by examiner]
International Search Report and Written Opinion mailed Apr. 19, 2018 in PCT/US17/50354. [cited by applicant]
Corrected International Preliminary Report on Patentability mailed Jan. 18, 2019 in PCT/US17/50354. [cited by applicant]
European Search Report mailed Feb. 17, 2020 in EP Application No. 17849489.4. [cited by applicant]
Notice of Reasons for Rejection mailed Apr. 15, 2020 in JP Application No. 2019-512800. [cited by applicant]
Notice on the First Office Action mailed Nov. 3, 2022 in CN Application No. 201780068285.4. [cited by applicant]
International Preliminary Report on Patentability mailed Oct. 11, 2018 in PCT/US2017/050354. [cited by applicant]
Office Action mailed Jul. 16, 2020 in CA Application No. 3,035,698. [cited by applicant]
Office Action mailed Jun. 25, 2021 in CA Application No. 3,035,698. [cited by applicant]
Office Action mailed Jul. 20, 2022 in CA Application No. 3,035,698. [cited by applicant]
Examination Report mailed Feb. 24, 2021 for CA Application No. 2017324946. [cited by applicant]